Video Latest - ecancer

The global platform for access to childhood cancer medicines

Dr James Downing - St. Jude Children’s Research Hospital, Memphis, USA

17 Dec 2021

Cancer medicine shortages for children around the world

Dr Carlos Rodriguez-Galindo - St. Jude Children’s Research Hospital, Memphis, USA

17 Dec 2021

Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-line treatment of CLL in elderly or unfit patients

Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands

14 Dec 2021

Tisagenlecleucel shows no EFS improvement on standard of care in 2L for aggressive B-cell NHL

Dr Michael Bishop - University of Chicago, Chicago, USA

14 Dec 2021

Latest in combination therapy for NDMM patients

Prof Luciano Costa - University of Alabama at Birmingham, Birmingham, USA

12 Dec 2021

ZUMA-12: A phase 2 study of axi-cel as first-line therapy in patients with high-risk large B-cell lymphoma (LBCL)

Prof Sattva Neelapu - The University of Texas MD Anderson Cancer Center, Houston, USA

11 Dec 2021

Mosunetuzumab induces deep and durable remissions in 3L R/R follicular lymphoma

Prof Elizabeth Budde - City of Hope, Duarte, USA

11 Dec 2021

Latest in advanced endometrial cancer

Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace Vergote

9 Dec 2021

OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

8 Dec 2021

Post-HSCT management of ALL - Adult ALL perspective

Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain

6 Dec 2021

Breast cancer treatment and ABC global alliance communication skills training workshop

Dr Fatima Cardoso - Champalimaud Clinical Center in Lisbon, Portugal

15 Nov 2021

Immunotherapy of T-ALL: Opportunities and hurdles

Dr Maksim Mamonkin - Baylor College of Medicine, Houston, USA

10 Nov 2021

Video